RxDoctor Payments Data

Abby Carter

Family · Campbellsville, KYNPI 1508425844

Payments from drug & device makers

$2,844in general payments, 2019–2025

Across 178 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$763
  • Johnson & Johnson$260
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$185
  • QOL Medical, LLC$146
  • Takeda Pharmaceuticals U.S.A., Inc.$137
  • Merz North America, Inc.$132
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$2,82299%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,844 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$39,242
Medicare patients
290
Services billed
408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide104$69,837
CreonLipase/Protease/Amylase28$40,737
IbsrelaTenapanor Hcl13$27,961
TrulancePlecanatide34$22,046
ClenpiqSod Picosulf/Mag Ox/Citric Ac96$16,484
Colestipol Hcl150$10,709
Mesalamine29$6,985
Budesonide DrBudesonide16$5,069
Balsalazide Disodium14$3,403
DexilantDexlansoprazole11$3,332
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag20$2,421
Pantoprazole Sodium236$2,247
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates36$1,951
Mesalamine ErMesalamine11$1,947
Sucralfate84$1,692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$763$110,574132 claims
Ardelyx, Inc.Ibsrela$77$27,96113 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$185$22,04634 claims
Ferring Pharmaceuticals Inc.Clenpiq$130$16,48496 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$137$3,33211 claims
Braintree Laboratories, Inc.Suflave$120$2,42120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Campbellsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →